1/7/2024, 7:13:02 pm

India panel urges drug regulator to approve Lilly's obesity drug Mounjaro

An Indian government expert panel has recommended approval for the import and sale of Eli Lilly's Mounjaro, a diabetes and obesity treatment, in certain doses for chronic weight management, pending a Phase 4 clinical trial. This is a major step towards approval in India, which has a large market for weight-loss treatments, with an estimated global market of $100 billion by 2035.